Polianta LTD Neurocrine Biosciences Inc Transaction History

Polianta LTD

  • $209 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 14, 2021
SELL
$87.57 - $119.4 $1.18 Million - $1.61 Million
-13,500 Closed
0 $0
Q4 2020

Jan 13, 2021
BUY
$86.91 - $108.33 $139,056 - $173,328
1,600 Added 13.45%
13,500 $1.29 Million
Q3 2020

Oct 07, 2020
BUY
$96.16 - $135.15 $1.14 Million - $1.61 Million
11,900 New
11,900 $1.14 Million

Others Institutions Holding NBIX

# of Institutions
635
Shares Held
93.5M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $14.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Polianta LTD Portfolio

Follow Polianta LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

News

Stay updated on Polianta LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email